Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis
Collectively, we provide the first evidence of the therapeutic effect of Hup A on DN, indicating that Hup A is a potential drug for the prevention and treatment of DN.
Authors
- Wenmin Wang (ORCID: https://orcid.org/0000-0003-2664-4413)
- Lidan Hu (ORCID: https://orcid.org/0000-0002-1145-2745)
- Qinghua Peng (ORCID: https://orcid.org/0000-0002-9378-1330)
- Cai-Feng Zhu
- Ying Zhang (ORCID: https://orcid.org/0000-0003-3139-3524)
- Yue Wang (ORCID: https://orcid.org/0009-0000-3993-3279)
- Maokun Liao
- Jiazhen Yin (ORCID: https://orcid.org/0000-0002-6117-1896)
- Weidong Li (ORCID: https://orcid.org/0000-0003-0521-7412)
- Yingping Xiao (ORCID: https://orcid.org/0000-0001-5143-0885)
- Xiangjun Chen (ORCID: https://orcid.org/0000-0003-0766-3416)
- Yayu Li (ORCID: https://orcid.org/0000-0001-7587-4691)
- Yuhan Ding (ORCID: https://orcid.org/0009-0006-3368-5941)
- Wunan Huang (ORCID: https://orcid.org/0009-0003-6781-7701)
- Yuelin Guan
- Zhongkai Cao
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- Zhejiang Provincial Hospital of TCM (CN)
- Children's Hospital of Zhejiang University (CN)
- ZheJiang Academy of Agricultural Sciences (CN)
- Hubei Normal University (CN)
- Zhejiang University (CN)
- Lanzhou University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Pharmacological Research
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1016/j.phrs.2024.107392
- Citations
- 4
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.79
Funders
- National Natural Science Foundation of China